$13.8 Billion is the total value of Rokos Capital Management LLP's 131 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLD | SPDR GOLD TRcall | $438,524,985 | -2.9% | 2,540,333 | 0.0% | 3.18% | -27.2% | |
| UBS | UBS GROUP AGcall | $128,839,001 | +22.7% | 5,200,000 | 0.0% | 0.94% | -8.0% | |
| KBH | KB HOMEput | $88,986,500 | -9.1% | 1,900,000 | 0.0% | 0.65% | -31.9% | |
| UBS | UBS GROUP AGput | $54,508,808 | +22.7% | 2,200,000 | 0.0% | 0.40% | -7.9% | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $45,031,997 | -23.5% | 1,675,921 | 0.0% | 0.33% | -42.6% | |
| NTLA | INTELLIA THERAPEUTICS INC | $44,311,596 | -21.5% | 1,389,296 | 0.0% | 0.32% | -41.1% | |
| CRM | SALESFORCE INC | $37,289,302 | -3.4% | 181,258 | 0.0% | 0.27% | -27.5% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $23,893,893 | +5.2% | 183,109 | 0.0% | 0.17% | -20.9% | |
| DLTR | DOLLAR TREE INC | $22,176,051 | -25.5% | 206,982 | 0.0% | 0.16% | -44.1% | |
| SNY | SANOFIsponsored adr | $14,590,419 | -0.1% | 271,753 | 0.0% | 0.11% | -24.8% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $13,949,859 | +35.9% | 1,355,013 | 0.0% | 0.10% | +2.0% | |
| CARIBOU BIOSCIENCES INC | $13,287,252 | +18.6% | 2,748,139 | 0.0% | 0.10% | -11.1% | ||
| MDB | MONGODB INCcl a | $6,797,886 | -13.9% | 19,085 | 0.0% | 0.05% | -35.5% | |
| ZS | ZSCALER INC | $5,873,804 | +6.4% | 37,012 | 0.0% | 0.04% | -18.9% | |
| YPF | YPF SOCIEDAD ANONIMAspon adr cl d | $5,300,251 | -16.6% | 425,894 | 0.0% | 0.04% | -38.7% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $4,074,875 | -16.8% | 87,500 | 0.0% | 0.03% | -36.2% | |
| SGMO | SANGAMO THERAPEUTICS INC | $3,940,936 | -51.1% | 6,474,348 | 0.0% | 0.03% | -62.8% | |
| ADI | ANALOG DEVICES INC | $3,859,668 | -9.1% | 21,848 | 0.0% | 0.03% | -31.7% | |
| CABA | CABALETTA BIO INC | $2,666,859 | +18.3% | 173,850 | 0.0% | 0.02% | -13.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC | 11 | Q3 2023 | 8.4% |
| ALPHABET INC | 10 | Q3 2023 | 12.8% |
| SALESFORCE INC | 10 | Q3 2023 | 3.6% |
| SNOWFLAKE INC | 10 | Q3 2023 | 1.6% |
| ALIBABA GROUP HLDG LTD | 9 | Q3 2023 | 34.2% |
| MICROSOFT CORP | 9 | Q3 2023 | 11.7% |
| SELECT SECTOR SPDR TR | 9 | Q3 2023 | 9.8% |
| PAYPAL HLDGS INC | 9 | Q3 2023 | 1.3% |
| CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 1.0% |
| SANGAMO THERAPEUTICS INC | 9 | Q3 2023 | 0.8% |
View Rokos Capital Management LLP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-08-11 |
| 13F-HR/A | 2022-05-16 |
View Rokos Capital Management LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.